Low Ferritin is Associated with Insomnia and Sleep Disturbances
Low ferritin levels are clinically associated with insomnia and various sleep disturbances, particularly restless legs syndrome (RLS), sleep fragmentation, and poor sleep quality, with iron supplementation showing benefit in select populations.
Mechanisms and Clinical Evidence
The relationship between low ferritin and insomnia operates through multiple pathways:
- Iron deficiency affects dopaminergic neurotransmission and may alter circadian gene expression, particularly in females 1
- Ferritin levels below 45-50 µg/L are consistently associated with sleep problems, even without frank anemia 2, 3, 4
- The association is strongest for RLS-related insomnia, where low iron stores directly contribute to symptom severity 3, 4
Population-Specific Findings
Children and Adolescents
Low ferritin (<30 ng/mL) in children presents with:
- Fatigability and insomnia as the most prevalent symptoms 5
- Sleep wake transition disorders and abnormal sleep movements when ferritin <45 µg/L 2
- Iron supplementation (3 mg/kg/day ferrous sulfate) significantly improved sleep quality scores (CGI-S, PSQI, CES-D) over 12 weeks 5
In teenagers with chronic insomnia, low ferritin (mean 17 µg/L) with low iron saturation (mean 9.7%) was correctable with oral iron, reducing subjective sleep latency from 143 to 23 minutes 3.
Sex-Specific Differences
Recent longitudinal data shows females are particularly vulnerable 1:
- Females in the lowest ferritin tertile had 1.35% higher sleep fragmentation during weekdays
- Lower ferritin associated with DNA methylation differences in circadian genes (CLOCK, PER1, RORC) specifically in females
- Males showed later weekend sleep timing with low ferritin
Clinical Thresholds and Diagnostic Approach
Key ferritin thresholds to evaluate:
- <45-50 µg/L: Associated with sleep wake transition disorders and RLS symptoms 2, 4
- <30 ng/mL: Linked to insomnia and psychological symptoms in children/adolescents 5
- <20 ng/mL with low-normal transferrin saturation: Suggests genetic iron metabolism disorder requiring further evaluation 6
Treatment Implications
Iron supplementation is effective for iron deficiency-related sleep disturbances (moderate-certainty evidence) 4:
- Oral ferrous sulfate (3 mg/kg/day in children, standard adult dosing) for 3-5 months
- Targets ferritin restoration and symptom improvement
- Most effective for RLS-related insomnia
- Monitor ferritin levels during treatment
Important Caveats
- One small RCT in autism spectrum disorder children showed no improvement in actigraphy-measured sleep onset latency despite ferritin improvement, though clinical global impression scores improved 7
- This suggests subjective sleep quality may improve even when objective sleep parameters don't change significantly
- Iron supplementation should not replace cognitive behavioral therapy for insomnia (CBT-I), which remains the first-line treatment for chronic insomnia disorder 8
Clinical Algorithm
Screen ferritin in patients with chronic insomnia, particularly:
- Teenagers/children with unexplained insomnia and fatigue
- Patients with RLS symptoms
- Females with sleep fragmentation
- Those with insomnia refractory to standard treatments
If ferritin <45-50 µg/L: Consider iron supplementation trial for 3-5 months while implementing CBT-I
If ferritin <20 ng/mL with abnormal iron studies: Evaluate for genetic iron metabolism disorders 6
Monitor response with both ferritin levels and sleep quality assessments (PSQI, sleep diaries)
The evidence supports checking ferritin levels in patients with chronic insomnia, especially when accompanied by fatigue, RLS symptoms, or treatment resistance, regardless of anemia status 5, 3, 4.